Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 40Rectal Neoplasms 21Colorectal Neoplasms 20Colonic Neoplasms 19Glioblastoma 13Pancreatic Neoplasms 12Carcinoma, Non-Small-Cell Lung 12Stomach Neoplasms 11Gliosarcoma 11Central Nervous System Neoplasms 11Esophageal Neoplasms 9Prostatic Neoplasms 8Lung Neoplasms 8Head and Neck Neoplasms 8Uterine Cervical Neoplasms 7Carcinoma, Intraductal, Noninfiltrating 7Adenocarcinoma Of Esophagus 7Squamous Cell Carcinoma of Head and Neck 6Sarcoma 6Ovarian Neoplasms 6Neoplasm Metastasis 6Carcinoma, Ovarian Epithelial 6Breast Neoplasms, Male 6Melanoma 5Esophageal Squamous Cell Carcinoma 5Breast Carcinoma In Situ 5Salivary Gland Neoplasms 4Nasopharyngeal Carcinoma 4Lymphoma 4Fallopian Tube Neoplasms 4

Interventions

Gemcitabine 24Cisplatin 14Capecitabine 12Oxaliplatin 11Fluorouracil 11Leucovorin 7Irinotecan 7Radiotherapy 5durvalumab 4Photochemotherapy 3Magnetic Resonance Spectroscopy 3Long-Term Synaptic Depression 3Erlotinib Hydrochloride 3Cholangiopancreatography, Endoscopic Retrograde 3Carboplatin 3trifluridine tipiracil drug combination 2regorafenib 2olaparib 2ceralasertib 2Stents 2Sorafenib 2Radiosurgery 2Radiofrequency Ablation 2Liver Transplantation 2Filgrastim 2Dihematoporphyrin Ether 21-phenyl-3,3-dimethyltriazene 2zimberelimab 1tivozanib 1titanium silicide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Bile Duct Neoplasms × Chemotherapy, Adjuvant × Clear all
NCT01313377 2017-01-25

Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery

UNICANCER

Phase 3 Completed
190 enrolled
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡